Skip to main content

 

Together, We Are AACE

  • ABOUT

  • OUR MISSION

We are a global, inclusive community of endocrine-focused clinical members, affiliates and partners from every walk of professional life. We promote both formal and informal knowledge-sharing through our publications and education- and communication-focused programs. We pride ourselves in offering a uniquely personal experience that gives every member of our community a voice. Learn More

Our mission is elevating the practice of clinical endocrinology to improve global health.Learn More

We are the organization focused on endocrinology, diabetes, and metabolism that is most:

  • Recognized worldwide for its clinical leadership

  • Valued by clinical endocrinologists and other healthcare professionals

  • Trusted by patients

  • Respected by healthcare decision-makers and the public

Learn More

THE LATEST NEWS &
UPDATES

  • The Health Care Workforce Shortage Issue In Congress

    The COVID-19 pandemic revealed to Federal public policymakers and the general public the need for more health care providers. More importantly, there was a greater realization of a shortage in underserved areas, particularly in certain urban, rural, and Native American settings. Learn how congress is solving the crisis in the health care workforce.

    The Health Care Workforce Shortage Issue In Congress
  • President Biden's FY 2022 Budget and Revenue Proposals

    On May 28, President Biden released his FY 2022 budget and revenue proposals. Learn about the breakdown of the health care budget proposals.

    President Biden's FY 2022 Budget and Revenue Proposals
  • Federal Policy Update

    On May 25, the Senate confirmed Chiquita Brooks-LaSure to be the Centers for Medicare and Medicaid Services Administrator by a vote of 55-44. She was sworn in two days later. In her first interview, Brooks-LaSure stated that her top priorities will be to expand health insurance coverage and address health disparities.

    Federal Policy Update
  • Community Perspective: FDA OKs Injectable Semaglutide for Chronic Weight Management

    Monica Agarwal MD, MEHP, FACE, provides her perspectives on the recent FDA approval of Semaglutide as an addition to the therapeutic armamentarium of weight management options for people living with obesity. Learn her key takeaways and how the new injectable semaglutide can support adults living with obesity.

    Community Perspective FDA OKs Injectable Semaglutide for Chronic Weight Management
  • Federal Policy Update - July 2021

    In June the U.S. Supreme Court came to the end of its term. Meanwhile, Congress has begun the budget/appropriations process. Learn about the latest federal policy updates and how it can impact the future of health care.

    Federal Policy Update
  • No Surprises Billing Proposed Regulations

    On July 1, 2021, the “No Surprises Act” Interim Final Rule, Part I, was issued. Learn how this announcement is the first in a series of regulations aimed at shielding patients from increased financial hardships stemming from surprise medical bills.

    No Surprises Billing Proposed Regulations
  • President/CEO Update to AACE Members – April 2020

    We continue to think of you during this unprecedented season. While over the last several weeks you have received many helpful pieces of guidance, research, and news updates - today we simply wish to remind you that our priority remains to be you: our members. You are the heart of AACE, and you are our foremost thought that guides anything and everything we do.

  • FDA Requests Withdrawal of Belviq XR (lorcaserin) from the Market

    Due to signals in safety clinical trials showing possible increased risk of cancer, The U.S. Food and Drug Administration (FDA) requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market.

  • U.S. President Takes Action to Lower Drug Prices for Americans

    President Trump signed four executive orders aimed at lowering the prices Americans pay for prescription drugs, including insulin.

COMMUNITY
PERSPECTIVES

I am proud to be an AACE member and to witness the continued growth of this organization.

Dr. Matthew Levine

Read More

One of our great strengths is our diversity: our growing AACE community represents a huge wealth and resource of people of diverse backgrounds.

Dr. Leslie Eldeiry

Read More

I am excited about our AACE and the place for clinical endocrinology in tomorrow’s health care ecosphere.

Dr. Sethu Reddy

Read More